Drug Shortage Report for GAMMAGARD LIQUID
| Report ID | 90434 |
| Drug Identification Number | 02279444 |
| Brand name | GAMMAGARD LIQUID |
| Common or Proper name | GAMMAGARD LIQUID, Immunoglobulin Intravenous |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IMMUNOGLOBULIN |
| Strength(s) | 10% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL |
| ATC code | J06BA |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-07-31 |
| Actual start date | 2019-07-31 |
| Estimated end date | 2019-09-30 |
| Actual end date | 2020-01-13 |
| Shortage status | Resolved |
| Updated date | 2020-02-06 |
| Company comments | Temporary shortage in some product size formats. Resolved as of 13Jan2020 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-07-31 | English | Compare |
| v2 | 2019-07-31 | English | Compare |
| v1 | 2019-07-31 | English | Compare |